Genetic showdown: can full genome sequencing outsmart rare gut disease?

NCT ID NCT04528303

Recruiting now Diagnosis Sponsor: Children's Hospital of Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether whole genome sequencing (looking at all DNA) finds more answers than whole exome sequencing (looking at just the protein-making parts) for children with long-lasting diarrhea and gut problems. About 180 children will be randomly assigned to one test or the other. The goal is to see which test leads to more accurate diagnoses and helps doctors choose better treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIARRHEA, INFANTILE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infantile diarrhea intestinal disorder protein-losing enteropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIARRHEA, INFANTILE ENTEROPATHY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ying Huang
RECRUITING

Shanghai, Shanghai Municipality, 201102, China

Contact Phone: •••-•••-•••• Email: •••••@•••••